Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gideon A Rodan

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Arthritis and Rheumatism|April 13, 2004
The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection modelTadashi Hayami, Maureen Pickarski, Gregg A Wesolowski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2002
IL-1 regulates cytoskeletal organization in osteoclasts via TNF receptor-associated factor 6/c-Src complexIchiro Nakamura, Yuho Kadono, Hiroshi Takayanagi, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 8, 2003
Receptor tyrosine kinases inhibit bone morphogenetic protein-Smad responsive promoter activity and differentiation of murine MC3T3-E1 osteoblast-like cellsKonosuke Nakayama, Yasuhiro Tamura, Miyuki Suzawa, et al.
Molecular Endocrinology (Baltimore, Md.)|May 8, 2004
The LATS2/KPM tumor suppressor is a negative regulator of the androgen receptorMark Powzaniuk, Sheila McElwee-Witmer, Robert L Vogel, et al.
Bioorganic & Medicinal Chemistry Letters|March 5, 2005
Nonpeptide alpha(v)beta3 antagonists: identification of potent, chain-shortened 7-oxo RGD mimeticsAmy E Zartman, Le T Duong, Carmen Fernandez-Metzler, et al.
Maturitas|August 15, 2009
Control of rat tail skin temperature regulation by estrogen receptor-beta selective ligandEvan E Opas, Angela Scafonas, Pascale V Nantermet, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Non-peptide alpha v beta 3 antagonists. Part 7: 3-Substituted tetrahydro-naphthyridine derivativesJiabing Wang, Michael J Breslin, Paul J Coleman, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2004
Nonpeptide alpha V beta 3 antagonists. Part 9: Improved pharmacokinetic profile through the use of an aliphatic, des-amide backboneDavid B Whitman, Ben C Askew, Le T Duong, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2003
Non-peptide alpha(v)beta(3) antagonists: identification of potent, chain-shortened RGD mimetics that incorporate a central pyrrolidinone constraintJames J Perkins, L T Duong, Carmen Fernandez-Metzler, et al.
The Journal of Steroid Biochemistry and Molecular Biology|May 30, 2008
Agonist-like SERM effects on ERalpha-mediated repression of MMP1 promoter activity predict in vivo effects on bone and uterusAngela Scafonas, Alfred A Reszka, Donald B Kimmel, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Arthritis and Rheumatism|April 13, 2004
The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection modelTadashi Hayami, Maureen Pickarski, Gregg A Wesolowski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2002
IL-1 regulates cytoskeletal organization in osteoclasts via TNF receptor-associated factor 6/c-Src complexIchiro Nakamura, Yuho Kadono, Hiroshi Takayanagi, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 8, 2003
Receptor tyrosine kinases inhibit bone morphogenetic protein-Smad responsive promoter activity and differentiation of murine MC3T3-E1 osteoblast-like cellsKonosuke Nakayama, Yasuhiro Tamura, Miyuki Suzawa, et al.
Molecular Endocrinology (Baltimore, Md.)|May 8, 2004
The LATS2/KPM tumor suppressor is a negative regulator of the androgen receptorMark Powzaniuk, Sheila McElwee-Witmer, Robert L Vogel, et al.
Bioorganic & Medicinal Chemistry Letters|March 5, 2005
Nonpeptide alpha(v)beta3 antagonists: identification of potent, chain-shortened 7-oxo RGD mimeticsAmy E Zartman, Le T Duong, Carmen Fernandez-Metzler, et al.
Maturitas|August 15, 2009
Control of rat tail skin temperature regulation by estrogen receptor-beta selective ligandEvan E Opas, Angela Scafonas, Pascale V Nantermet, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Non-peptide alpha v beta 3 antagonists. Part 7: 3-Substituted tetrahydro-naphthyridine derivativesJiabing Wang, Michael J Breslin, Paul J Coleman, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2004
Nonpeptide alpha V beta 3 antagonists. Part 9: Improved pharmacokinetic profile through the use of an aliphatic, des-amide backboneDavid B Whitman, Ben C Askew, Le T Duong, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2003
Non-peptide alpha(v)beta(3) antagonists: identification of potent, chain-shortened RGD mimetics that incorporate a central pyrrolidinone constraintJames J Perkins, L T Duong, Carmen Fernandez-Metzler, et al.
The Journal of Steroid Biochemistry and Molecular Biology|May 30, 2008
Agonist-like SERM effects on ERalpha-mediated repression of MMP1 promoter activity predict in vivo effects on bone and uterusAngela Scafonas, Alfred A Reszka, Donald B Kimmel, et al.
Pageof 5